Partial amino acid sequence of HLA-A9 antigen purified with a specific xenoantiserum.
James P. Allison(The University of Texas MD Anderson Cancer Center), Ralph A. Reisfeld, Michele Pellegrino(University of Calabria), Soldano Ferrone(Massachusetts General Hospital), Jack Silver(New York University Langone Orthopedic Hospital), L E Walker(Unknown)
PubMed
December 1, 1978
Cited by 17
Related Papers
Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
|New England Journal of Medicine|2012|2.1k
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
|Clinical Cancer Research|2009|1.4k
Cancer classification using the Immunoscore: a worldwide task force
|Journal of Translational Medicine|2012|803
The Next Decade of Immune Checkpoint Therapy
|Cancer Discovery|2021|739